Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | OPRM1 | P35372 | 19/20 | 0.39 |
| ▸ | OPRK1 | P41145 | 19/20 | 0.39 |
| ▸ | OGFRL1 | Q5TC84 | 19/20 | 0.39 |
| ▸ | OPRD1 | P41143 | 15/20 | 0.39 |
| ▸ | OPRL1 | P41146 | 3/20 | 0.37 |
| ▸ | PRKACA | P17612 | 1/20 | 0.35 |
| ▸ | RPS6KB1 | P23443 | 1/20 | 0.35 |
| ▸ | GSK3B | P49841 | 1/20 | 0.35 |
| ▸ | ROCK1 | Q13464 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL28948662 | 0.93 | OPRM1 (0.39) | OPRM1OPRK1OGFRL1OPRD1OPRL1 | |
| SCHEMBL28819534 | 0.89 | OPRM1 (0.41) | OPRM1OPRK1OGFRL1OPRD1OPRL1 | |
| SCHEMBL28819662 | 0.88 | OPRM1 (0.38) | OPRM1OPRK1OGFRL1OPRD1OPRL1 | |
| SCHEMBL28819657 | 0.88 | OPRM1 (0.39) | OPRM1OPRK1OGFRL1OPRD1OPRL1 | |
| SCHEMBL28819527 | 0.85 | OPRM1 (0.41) | OPRM1OPRK1OGFRL1OPRD1OPRL1 | |
| SCHEMBL28819530 | 0.84 | MCHR1 (0.44) | OPRM1OPRK1OGFRL1OPRD1OPRL1 | |
| SCHEMBL28819696 | 0.83 | OPRM1 (0.41) | OPRM1OPRK1OGFRL1OPRD1OPRL1 | |
| SCHEMBL28819597 | 0.82 | OPRM1 (0.39) | OPRM1OPRK1OGFRL1OPRD1OPRL1 | |
| SCHEMBL28819538 | 0.82 | OPRM1 (0.40) | OPRM1OPRK1OGFRL1OPRD1OPRL1 | |
| Hydrochloric Acid SCHEMBL28819554 | 0.81 | OGFRL1 (0.45) | OPRM1OPRK1OGFRL1OPRD1OPRL1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-110404073-B | Methods and pharmaceutical compositions for treating hepatitis B virus infection | 国家医疗保健研究所 | 2022-08-16 | — | — | CN | disclosed |